Terms ending in 2033
Every in-force patent on Helix, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,060,207 | Riser System and Method of Use In force · High confidence | Helix Energy Solutions Group, Inc. | In force | High confidence | |
| US 9,278,994 | Short Antimicrobial Lipopeptides In force · High confidence | Helix Biomedix, Inc. | In force | High confidence | |
| US 9,149,675 | Therapy Device For Trismus Prevention And Treatment In force · High confidence | Freudenberg Medical, LLC | In force | High confidence | |
| US 8,986,732 | Biphasic Lipid-Vesicle Compositions and Methods for Treating Cervical Dysplasia by Intravaginal Delivery In force · High confidence | Altum-Avro Pharma Partnership | In force | High confidence | |
| US 8,992,969 | Biphasic Lipid-Vesicle Compositions and Methods for Treating Cervical Dysplasia by Intravaginal Delivery In force · Medium confidence | Altum-Avro Pharma Partnership | In force | Medium confidence | |
| US 9,011,924 | Biphasic Lipid-Vesicle Compositions and Methods for Treating Cervical Dysplasia by Intravaginal Delivery In force · High confidence | Altum-Avro Pharma Partnership | In force | High confidence | |
| US 10,159,646 | Biphasic Lipid-Vesicle Compositions and Methods for Treating Cervical Dysplasia by Intravaginal Delivery In force · High confidence | Altum-Avro Pharma Partnership | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Helix, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.